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http://dx.doi.org/10.1016/j.jtho.2015.08.005A 65-year-old man who had undergone a right pneu-
monectomy for a pT2bN0M0 large cell carcinoma 5
years earlier was referred to our institution for evalua-
tion of a splenic nodule detected during regular follow-
up. The patient was asymptomatic and his physical
examination and laboratory tests were unremarkable.
A total-body computed tomography scan revealed an
isolated approximately 5-cm splenic mass (Fig. 1A). No
other uncommon ﬁndings were reported. Positron
emission tomography–computed tomography demon-
strated high accumulation of 18F-ﬂuorodeoxyglucose
in the splenic mass with a maximal standardized
uptake value of 22.4 and no evidence of metabolically
active lymphadenopathy or other parenchymal masses
(Fig. 1B). The patient underwent a splenectomy with a
high epidural block. The histological evaluation
conﬁrmed the suspicion of isolated splenic metastasesJournal of Thoracic Oncology Vol. 11 No. 1: 128-129from a large cell lung carcinoma (Fig. 2). At 16 months
follow-up, the patient is free from disease.
Splenic metastases from solid tumors are rare and
usually occur in association with disseminated disease. In
the reported autopsy series, the rate of spleen metastases
varied widely between 2.3% and 7.1%1; however, fewer
than 100 cases of isolated splenic metastases with
Figure 2. (A) Microscopic appearance of a neoplastic nodule inside the pulpa splenica, e/e (magniﬁcation 4). (B) Higher
magniﬁcation of solid neoplastic nests.
January 2016 Spleen as Primary Lung Cancer Metastasis Site 129different origins (mainly from ovarian and colorectal
cancer) have been reported in the literature.1 Solitary
splenic metastases from primary lung cancer is extremely
rare, and to the best of our knowledge, only nine cases
with a metachronous appearance have been reported
in the English-language literature.2 When a neoplastic
lesion of the spleen is suspected, a detailed staging is
mandatory to exclude occult systemic disease. Although
no guidelines for the surgical treatment of isolated splenic
metastasis are available at present, the survival time
after splenectomy ranges between 1 and 49 months, with
one patient still alive after 8 years.2 Furthermore, surgery
can prevent symptomatic splenomegaly and potentiallylife-threatening complications such as splenic rupture
and splenic vein thrombosis.3
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